01—Abstract
Summary
Summary of the 8-K filed February 7, 2024. Cited figures are marked; the original filing is the authoritative source.
Omega Healthcare Investors, Inc. (NYSE: OHI) reported fourth-quarter 2023 net income of $57 milliona, or $0.22 per common share, up from $47 million, or $0.19 per share, in the fourth quarter of 2022.
Nareit FFO was $129 millionb, or $0.50 per share, compared with a loss of $30 million, or $0.13 per share, a year earlier. Adjusted FFO (AFFO) was $173 million, or $0.68 per share, versus $177 million, or $0.73 per share, and FAD was $163 million, or $0.64 per share, versus $171 million, or $0.70 per share. For full-year 2023, net income was $249 million, or $1.00 per share, compared with $439 million, or $1.80 per share, in 2022.
Full-year AFFO was $699 millionc, or $2.79 per share, versus $730 million, or $2.99 per share, in 2022. Management said operating performance is improving, with occupancy above 80% and EBITDAR coverage of 1.28x, a post-pandemic high. The company expects first- and second-quarter 2024 earnings to remain affected by operator restructurings, with improvement later in the year.
It provided 2024 AFFO guidance of $2.70 to $2.80d per diluted share, its first annual AFFO guidance since the pandemic. The board declared a quarterly dividend of $0.67 per share, payable February 15, 2024. The filing flags operator risk, including Guardian Healthcare's failure to make its fourth-quarter contractual rent payments.
The company is in discussions to sell or re-lease the six remaining Guardian facilities. Management also cited the pending CMS final rule on minimum staffing as the primary remaining concern. At year-end, the company reported $5.1 billion of outstanding indebtedness at a weighted-average annual interest rate of 4.4%, $442.8 million of cash, and $1.43 billion of undrawn revolver capacity.
02—Key points
Key Highlights
- Q4 2023 net income of $57 million ($0.22 per share) compared with $47 million ($0.19 per share) in Q4 2022; Q4 Nareit FFO of $129 million ($0.50 per share) versus a loss of $30 million in the prior-year quarter.
- Full-year 2023 AFFO of $699 million ($2.79 per share), down from $730 million ($2.99 per share) in 2022; full-year FAD of $657 million ($2.62 per share) versus $678 million ($2.77 per share).
- 2024 AFFO guidance of $2.70 to $2.80 per diluted share, the first annual AFFO guidance provided since the pandemic.
- Investments totaled $249 million in Q4 2023 and $667 million for the full year, including $322 million in real estate loans and other loans and investments for 2023.
- Sold 69 facilities in 2023 for $485 million in consideration, plus repayment of a $105 million seller note, generating an $80 million gain on assets sold.
- Guardian Healthcare failed to make its Q4 contractual rent payments; the company is in discussions to sell or re-lease its six remaining Guardian facilities.
- Balance sheet: $5.1 billion of indebtedness at a 4.4% weighted-average rate, $442.8 million of cash, and $1.43 billion of undrawn revolver capacity; quarterly dividend of $0.67 per share declared.
03—Questions
Frequently Asked Questions
What drove the year-over-year change in Omega's earnings?
Q4 2023 net income rose to $57 million from $47 million, mainly because total expenses fell $82.2 million and revenues rose $94.5 million. These gains were partly offset by a $162.9 million decline in other income, largely due to a $170.5 million decrease in gain on assets sold. For full-year 2023, net income fell to $249 million from $439 million, mainly because gains on assets sold declined by $280.3 million.
What is Omega's 2024 earnings outlook?
Omega expects 2024 AFFO of $2.70 to $2.80 per diluted share. Management expects first- and second-quarter 2024 earnings to continue to be affected by operator restructuring efforts, with earnings expected to improve as the year progresses. The guidance assumes $94 million in asset sales and repayment of $400 million in senior unsecured debt due in 2024, and excludes additional acquisitions and asset sales.
How is the company's operator portfolio performing?
Management said occupancy is now above 80% and EBITDAR coverage reached 1.28x, a post-pandemic high. The share of the portfolio in the under 1.0x EBITDAR coverage bucket fell from 27.5% to 13.2%. Guardian Healthcare failed to make its Q4 contractual rent payments, and the company applied $4.4 million of Guardian's security deposit to Q4 revenue.
What are the main risks highlighted in the filing?
Management identified the pending CMS final rule on minimum staffing for skilled nursing facilities as the primary remaining concern, arguing the proposed rule has fundamental flaws given labor shortages. The filing also notes operator restructurings and transitions that continue to weigh on earnings, the Guardian rent default, and the possibility that additional operators are placed on a cash basis for revenue recognition.
What is the company's balance sheet position?
As of December 31, 2023, Omega had $5.1 billion of outstanding indebtedness with a weighted-average annual interest rate of 4.4%, including $4.55 billion of senior unsecured notes. It held $442.8 million of cash and equivalents and $1.43 billion of undrawn capacity under its unsecured revolving credit facility. The company also repaid $350 million of senior unsecured notes due August 1, 2023.
04—Continue